Company Analysis

Compass Therapeutics, Inc. (CMPX)

Nasdaq: CMPX · Biological Products, (No Diagnostic Substances) · Boston, MA · filing with the SEC since 2018
Grade4.7
◀ Past 4.0● Present 5.5▶ Future 4.4
4 est.

Who runs Compass Therapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Schuetz Thomas J.
CHIEF EXECUTIVE OFFICER. First filing Jun 2020, latest Feb 10, 2026, 23 filings in all.
Officers reporting now
6
of 12 people with a filing in the last fifteen months
Directors reporting now
6
25 people on the record since 2018
Officerssales are open-market, Oct 2, 2025 to Oct 2, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Lerner NeilChief Accounting OfficerDec 2024Oct 2, 2026none
Anderman JonathanGeneral CounselAug 2024Apr 30, 2026none
Schuetz Thomas J.CHIEF EXECUTIVE OFFICERJun 2020Feb 10, 2026none
Shin BarryCFODec 2024Jan 5, 2026none
Prasad ArjunChief Commercial OfficerJan 2026Jan 5, 2026none
Sirard CynthiaChief Medical OfficerJan 2026Jan 5, 2026none
Directorssales are open-market, Oct 2, 2025 to Oct 2, 2026
NameRoleFirst filingLatest filingSales, 12 months
Boylan James PdirectorNov 2022Jan 5, 2026none
Chiniara EllendirectorApr 2022Jan 5, 2026none
Ferneau PhilipdirectorJun 2020Jan 5, 2026none
Gordon Carl LdirectorJun 2020Jan 5, 2026none
Gray Mary AnndirectorApr 2022Jan 5, 2026none
Lindahl Richard SdirectorApr 2023Jan 5, 2026none
Earlier names on the record14, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CMPX · research, not advice